Everforth vs Booz Allen Hamilton: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Everforth, Inc. (EFOR)

Q3 202614 Jul – 24 Sep 2026

▲2▼2

Everforth's consulting slump deepens, but federal contract wins and a guidance beat steady the stock

Consulting demand stalls as AI hardware eats budgets IBM's revenue warning showed big companies are shifting spending to AI servers and chips, delaying large consulting deals. Everforth fell 5.4% as investors feared the same slowdown would hit its commercial business. This is the core problem weighing on the stock.
Explains the demand weakness that is the main drag on EFOR's price.
Weak guidance crushed the stock, then a Truist upgrade bounced it Everforth reported flat revenue and gave weak guidance, sending shares down 53.7% — the worst in its peer group. Days later Truist upgraded it to Buy, and the stock jumped 14.6% on hopes consulting growth returns. The upgrade is a bet, not proof the slump is over.
Captures the period's biggest price driver: the guidance-driven collapse and the analyst upgrade rebound.
Q2 beat guidance and Everforth led peers on guidance raises Everforth's Q2 revenue of $1.01 billion and EBITDA of $96.7 million both cleared the high end of its own guidance, and it delivered the highest guidance raise among IT services peers. That steadied the stock after the earlier collapse, though revenue was still down 1.3% from a year ago.
Shows the fundamental counterweight: results beat expectations even as the top line shrank.
Federal arm wins $178M in new defense and AI contracts Everforth ECS won a $30 million Defense Health Agency modernization deal and a $148 million SUNet contract extension, plus a SUNet 2.0 prototyping selection. These are concrete new orders that support the federal segment, though its book-to-bill of 0.8 shows orders still lag revenue.
New contract wins are the clearest positive catalyst for future revenue.

August 202614 Jul – 24 Sep 2026

▲2▼2

Everforth's consulting slump deepens, but federal contract wins and a guidance beat steady the stock

Consulting demand stalls as AI hardware eats budgets IBM's revenue warning showed big companies are shifting spending to AI servers and chips, delaying large consulting deals. Everforth fell 5.4% as investors feared the same slowdown would hit its commercial business. This is the core problem weighing on the stock.
Explains the demand weakness that is the main drag on EFOR's price.
Weak guidance crushed the stock, then a Truist upgrade bounced it Everforth reported flat revenue and gave weak guidance, sending shares down 53.7% — the worst in its peer group. Days later Truist upgraded it to Buy, and the stock jumped 14.6% on hopes consulting growth returns. The upgrade is a bet, not proof the slump is over.
Captures the period's biggest price driver: the guidance-driven collapse and the analyst upgrade rebound.
Q2 beat guidance and Everforth led peers on guidance raises Everforth's Q2 revenue of $1.01 billion and EBITDA of $96.7 million both cleared the high end of its own guidance, and it delivered the highest guidance raise among IT services peers. That steadied the stock after the earlier collapse, though revenue was still down 1.3% from a year ago.
Shows the fundamental counterweight: results beat expectations even as the top line shrank.
Federal arm wins $178M in new defense and AI contracts Everforth ECS won a $30 million Defense Health Agency modernization deal and a $148 million SUNet contract extension, plus a SUNet 2.0 prototyping selection. These are concrete new orders that support the federal segment, though its book-to-bill of 0.8 shows orders still lag revenue.
New contract wins are the clearest positive catalyst for future revenue.

Latest14 Jul – 24 Sep 2026

▲2▼2

Everforth's consulting slump deepens, but federal contract wins and a guidance beat steady the stock

Consulting demand stalls as AI hardware eats budgets IBM's revenue warning showed big companies are shifting spending to AI servers and chips, delaying large consulting deals. Everforth fell 5.4% as investors feared the same slowdown would hit its commercial business. This is the core problem weighing on the stock.
Explains the demand weakness that is the main drag on EFOR's price.
Weak guidance crushed the stock, then a Truist upgrade bounced it Everforth reported flat revenue and gave weak guidance, sending shares down 53.7% — the worst in its peer group. Days later Truist upgraded it to Buy, and the stock jumped 14.6% on hopes consulting growth returns. The upgrade is a bet, not proof the slump is over.
Captures the period's biggest price driver: the guidance-driven collapse and the analyst upgrade rebound.
Q2 beat guidance and Everforth led peers on guidance raises Everforth's Q2 revenue of $1.01 billion and EBITDA of $96.7 million both cleared the high end of its own guidance, and it delivered the highest guidance raise among IT services peers. That steadied the stock after the earlier collapse, though revenue was still down 1.3% from a year ago.
Shows the fundamental counterweight: results beat expectations even as the top line shrank.
Federal arm wins $178M in new defense and AI contracts Everforth ECS won a $30 million Defense Health Agency modernization deal and a $148 million SUNet contract extension, plus a SUNet 2.0 prototyping selection. These are concrete new orders that support the federal segment, though its book-to-bill of 0.8 shows orders still lag revenue.
New contract wins are the clearest positive catalyst for future revenue.

Booz Allen Hamilton Holding (BAH)

Q3 202624 Jul – 16 Sep 2026

▼3▲1

BAH's revenue shrinks as AI data rules and new rivals bite

Revenue decline and soft guidance Booz Allen's quarterly revenue fell 4.2% to $2.8 billion, missing expectations, and its full-year revenue outlook of $11.2–11.7 billion implies little growth. Falling sales pull the stock down because investors pay for future earnings power.
This is the core financial result that directly drives BAH's valuation.
Hiring rebound signals demand Booz Allen is accelerating hiring after last year's layoffs, part of a broader U.S. hiring rebound. More staff usually means more billable work ahead, which supports future revenue and lifts the stock.
Shows a real counterweight: demand may be recovering even as current revenue lags.
New federal AI rival Innodata is pushing into U.S. federal AI evaluation and red-teaming, directly overlapping Booz Allen's services. More competition for government AI contracts could pressure pricing and market share, weighing on the stock.
A new competitor in BAH's core federal AI niche threatens future growth.
AI data-retention limits Booz Allen barred Anthropic's Fable model from client cybersecurity work over data-retention and IP concerns, part of a wider enterprise pullback from frontier AI. Losing cutting-edge tools can slow delivery and raise costs, hurting the stock.
Restricted access to top AI models directly affects BAH's ability to serve clients.

August 202624 Jul – 16 Sep 2026

▼3▲1

BAH's revenue shrinks as AI data rules and new rivals bite

Revenue decline and soft guidance Booz Allen's quarterly revenue fell 4.2% to $2.8 billion, missing expectations, and its full-year revenue outlook of $11.2–11.7 billion implies little growth. Falling sales pull the stock down because investors pay for future earnings power.
This is the core financial result that directly drives BAH's valuation.
Hiring rebound signals demand Booz Allen is accelerating hiring after last year's layoffs, part of a broader U.S. hiring rebound. More staff usually means more billable work ahead, which supports future revenue and lifts the stock.
Shows a real counterweight: demand may be recovering even as current revenue lags.
New federal AI rival Innodata is pushing into U.S. federal AI evaluation and red-teaming, directly overlapping Booz Allen's services. More competition for government AI contracts could pressure pricing and market share, weighing on the stock.
A new competitor in BAH's core federal AI niche threatens future growth.
AI data-retention limits Booz Allen barred Anthropic's Fable model from client cybersecurity work over data-retention and IP concerns, part of a wider enterprise pullback from frontier AI. Losing cutting-edge tools can slow delivery and raise costs, hurting the stock.
Restricted access to top AI models directly affects BAH's ability to serve clients.

Latest24 Jul – 16 Sep 2026

▼3▲1

BAH's revenue shrinks as AI data rules and new rivals bite

Revenue decline and soft guidance Booz Allen's quarterly revenue fell 4.2% to $2.8 billion, missing expectations, and its full-year revenue outlook of $11.2–11.7 billion implies little growth. Falling sales pull the stock down because investors pay for future earnings power.
This is the core financial result that directly drives BAH's valuation.
Hiring rebound signals demand Booz Allen is accelerating hiring after last year's layoffs, part of a broader U.S. hiring rebound. More staff usually means more billable work ahead, which supports future revenue and lifts the stock.
Shows a real counterweight: demand may be recovering even as current revenue lags.
New federal AI rival Innodata is pushing into U.S. federal AI evaluation and red-teaming, directly overlapping Booz Allen's services. More competition for government AI contracts could pressure pricing and market share, weighing on the stock.
A new competitor in BAH's core federal AI niche threatens future growth.
AI data-retention limits Booz Allen barred Anthropic's Fable model from client cybersecurity work over data-retention and IP concerns, part of a wider enterprise pullback from frontier AI. Losing cutting-edge tools can slow delivery and raise costs, hurting the stock.
Restricted access to top AI models directly affects BAH's ability to serve clients.